Nineteen biscoumarins bearing free and modified hydroxyl substituents at benzoyloxyphenyl linker have been synthesized by multiple step synthesis. Among these biscoumarins, thirteen were found to be active molecules against HIV-1 integrase (HIV-1 IN) . The structure-activity relationship of the nineteen compounds on HIV IN may be useful for the design of potent therapeutic agents.
Because the integration is essential for the replication of HIV and the integrase, the enzyme responsive for integration, appears to be absent in the mammalian host, HIV-1 integrase (HIV-1 IN) represents a potential target for the development of non-toxic antiviral therapeutic agents. 3, 4) Recently numerous coumarin compounds have been evaluated for inhibitory effects against HIV replication, and some of them have been found to inhibit different stages in the HIV replication cycle. 5) A natural tetrameric coumarin (I) shown potent integrase inhibitory activity (IC 50 ϭ0.8 mM for integration and 1.5 mM for 3Ј-processing) was first reported by Mazumder et al. 6 ) and the parent compound was then modified into simple components to determine the minimum active pharmacophore essential for potency. They disclosed a biscoumarin unit linked by a phenyl ring (II) was required for activity. 7) Our previous studies focused mainly on the linker of phenyl ring. Replacement of the phenyl ring by aniline mustard (III) was achieved. 8) We reasoned the mustard moiety might react with nearby nucleophile of the binding site to form a covalent bonding and to improve the inhibitory activity. However, these compounds failed to enhance activity. We also prepared biscoumarins with a diversified modification on the linker. 9) Structure-activity relationship studies enabled us to know that the benzoyloxyphenyl linker (IV) seemed important for the inhibitory activity. These encouraging results prompted us to modify these lead compounds. Thus, we examined the effects of substitutions on the benzene ring of benzoyloxyphenyl linker. In the present paper, we report the synthesis and biological evaluation of a novel benzoyloxyphenyl linker (V) having either a monohydroxy or bishydroxy groups on the benzoyl ring.
Chemistry A general synthetic route for the preparation of target compounds (30-47) is depicted in Charts 2 and 4. Protection of the phenolic hydroxyl groups of commercially available polyphenolic acids (1) (2) (3) (4) (5) (6) (7) (8) by acetylation with acetic anhydride in pyridine in the dark at room temperature gave (9-16). Key intermediate 17 was prepared from 4-hydroxybenzaldehyde with 4-hydroxycoumarin in ethanol under reflux. The first attempt to prepare target compounds by esterification of 17 with protected polyphenolic acids (14) in the presence of coupling reagents dicyclohexylcarbodiimide (DCC) and catalyst 4-dimethylaminopyridine (4-DMAP) in dichloromethane, followed by 3 N HCl hydrolysis to remove the protected phenols was unfruitful (Chart 3). The product was unexpected 18 other than 45. Alternative synthesis of target compounds was successful by esterification of 4-hydroxybenzaldehyde with protected polyphenolic acids (9-16, 19) and lipoic acid in the presence of coupling reagents DCC and DMAP in dichloromethane and then subsequently coupling reaction with 4-hydroxycoumarin in ethanol under reflux (Chart 4). All the structures of target compounds were established by NMR, IR, MS spectroscopy and elementary analysis. The proton on the benzylidene tertcarbon of 45 is found at d 6.3 ppm, in agreement with previous studies on similar compounds. 8, 9) However, an unexpected benzylidene proton upfield shift from d 6.3 to 4.9 ppm is observed in 18. The introduction of an ester instead of ketone group on the 4-hydroxycoumarin ring in 18 decreases electron withdrawing ability, which causes the benzylidene proton upfield shifting. Since it was found that there were three reactive sites (two hydroxyls of 4-hydroxycoumarin and one hydroxyl of phenol) for the reaction of 17 with protected polyphenolic acids, molecular orbital calculation was carried out by using the program SPARTAN '04 windows, version 1.0.3 of Wavefunction Inc to verify the preferred reactive site for esterification. The net-charges by Hartree-Fock 3-21G(*) calculation for 17 are shown in Fig.  1 . The values of net-charge at two oxygen atoms from hydroxyl of 4-hydroxycoumarin in 17 are nearly equal (Ϫ0.798602 and Ϫ0.798694, respectively), while the oxygen atom of phenol has a value of Ϫ0.746966. The net-charges at oxygen atoms from hydroxyls of 4-hydroxycoumarin are negatively larger than that at oxygen atom of phenol. Thus, the 4-hydroxycoumarin hydroxyl groups are more reactive than the phenol hydroxyl group in 17 for esterification, and these results agree with the experimental fact.
Results and Discussion
HIV-1 IN Inhibition HIV-1 IN inhibition assays were carried out in the presence of low amounts of purified recombinant integrase (50 nM) in the presence of 7.5 mM Mg 2ϩ as the cationic cofactor, using 21-mer double-strand oligonucleotide substrate. The compounds were screened for their inhibitory activity in a 3Ј-processing assay which was performed as described previously. 3, 10) Effects against the strand transfer activity were evaluated during the same assay from the homologous integration events and found to be no significant differences from 3Ј-processing inhibition, thus confirming that coumarins affect equally both steps of the integration reaction. Table 1 lists the inhibitory activity of a series of mono-or bis-hydroxylated benzoyl biscoumarins against the recombinant wild-type HIV-1 IN enzyme. The inhibitory activity of NSC 158393 I and II were included for a comparison. Among nineteen compounds in this series, all were active, thirteen demonstrated activities less than 10 mM, four had activities in the range of 10 to 27 mM, and two showed activities at 37 and 53 mM, respectively. Compound 45 was the most potent in this series, with IC 50 of 1.5 mM. The second-most-potent compound 35 was the acetate analog of 45, with IC 50 of 1.9 mM. Compounds were divided into two classes based on the free (class I) or modified (class II) hydroxyl substitute. All the compounds in class I, bearing free hydroxyl substitute(s) (40-47), except compound 44 and 46, had a slight higher IN inhibitory activity in vitro than the corresponding compounds with modified hydroxyl substitute (30-38). The relative potency of the mono-hydroxyl compounds was in the order: 4-OH (42)Ͼ3-OH (41)Ͼ2-OH (40), whereas the bis-hydroxyl compounds was in the order: (46), suggesting the inhibitory activity is associated with the specific spatial disposition of the hydroxyl groups. Compound 47 (containing free hydroxyl caffeoyl) and 45 (having catechol) displayed considerable activity, with IC 50 of 2.6 and 1.5 mM, respectively. It was of interesting that compound 37 (containing protected methoxy caffeoyl) and 38 (containing protected acetoxy caffeoyl) were equal potent to 47, implying modification on bis-hydroxyl substitute tolerates activity. Class II compounds demonstrated similar trends to class I compounds on relative potency, except 33 and 36. Additionally, compound 39, replacing the caffeoyl with a potent antioxidative lipoyl moiety remained the potency, with IC 50 of 2.3 mM.
In conclusion, we have designed and synthesized nineteen biscoumarins bearing free and modified hydroxyl substitute at the benzoyl ring. Among these easily available biscoumarins, thirteen were found to be active molecules against HIV-1 IN. These compounds may prove useful in structure-activity relationship studies on HIV IN and may ultimately lead to new classes of potent therapeutic agents. Further detailed studies of the biological activity of these compounds will reveal their full potential.
Experimental
General Melting points (mp) were taken on a BUCHI 530 apparatus and are uncorrected. Merck Art No105554 plates precoated with Silica gel 60 containing fluorescent indicator were used for thin-layer chromatography, and Silica gel 60 (Merck Art No 109385, 230-400 mesh) was employed for column chromatography. Evaporations were carried out at Ͻ50°C using a rotary evaporator at reduced pressure (water aspirator).
1 H-and 13 C-NMR spectra were obtained at Varian 300 NMR spectrometer at 300 and 75 MHz, respectively. Where necessary, deuterium exchange experiments were used to obtained proton shift assignments. Mass spectra were recorded on a JEOL J.M.S-300 spectrophotometer. Analytical samples were dried under reduced pressure at 78°C in the presence of P 2 O 5 for at least 12 h unless otherwise specified. Elemental analyses were obtained from Perkin-Elmer 2400 Elemental Analyzer.
Acetylation of Phenol(s) of Polyphenolic Acid, General Procedure to Obtain Compounds 9-16 To a solution of polyphenolic acid (20 mmol) was added acetic anhydride (6 eq) and pyridine (2 ml). The mixture was stirred at room temperature under dark for 4 h. Then poured onto 1 M H 3 PO 4 (10 ml) cold solution. The mixture was extracted with ethyl acetate. The layers washed with brine and aq saturated sodium bicarbonate. The combined organic phase was dried under magnesium sulfate, filtered, and the solvent was removed under vacuo. The residue was crystallized from proper solvent to afford the corresponding acetoxy polyphenolic acids: 2-acetoxy benzoic acid (9), 3-acetoxy benzoic acid (10), 4-acetoxy benzoic acid (11), 2,4-diacetoxy benzoic acid (12), 2,5-diacetoxy benzoic acid (13), 3,4-diacetoxy benzoic acid (14), 3,5-diacetoxy benzoic acid (15), 3,4-diacetoxy cinnamic acid (16). These acetoxy polyphenolic acids were identified by melting point and 1 H-NMR. Data were in agreement with literature values. 11, 12) 3,3-(4-Hydroxybenzylidene)bis-4-hydroxycoumarin (17) A mixture of 4-hydroxybenzaldeyde (3.66 g, 30 mmol) and 4-hydroxycoumarin (9.73 g, 60 mmol) in absolute ethanol (100 ml) was heated under reflux for 24 h. The solvent was removed in vacuo. The residue was recrystallized from ethanol to give pale yellow powder 17 (11.4 g, 97%). Rf: 0.10 (nhexane : EtOAcϭ1 : 1 Esterification of Acetoxy (Poly)phenolic Acids or Lipoic Acid with 4-Hydroxybenzaldehyde, General Procedure to Obtain Compounds 20-29 To a solution of acid (10 mmol) and DCC (11 mmol) in CH 2 Cl 2 (50 ml) were added DMAP (1 mmol) and 4-hydroxybenzaldehyde (11 mmol). The reaction mixture was stirred over night at room temperature. The mixture was filtered, and the solvent was removed in vacuo. The residue was purified by flash chromatography on silica gel with CH 2 Cl 2 /acetone (9/1) and recrystallized from methanol.
4-(2-Acetoxybenzoyloxy)benzaldehyde (20) as white powder in a yield of 79%: mp: 74-75°C (n-hexane). 
